|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-1-9
|
|
pubmed:abstractText |
Experimental studies suggest that the antiproliferative effect of heparin after arterial injury is maximized by pretreatment. No previous studies of restenosis have used a pretreatment strategy. We designed this study to determine whether treatment with nadroparin, a low-molecular-weight heparin, started 3 days before the procedure and continued for 3 months, affected angiographic restenosis or clinical outcome after coronary angioplasty.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
pubmed-author:BertrandBB,
pubmed-author:BertrandM EME,
pubmed-author:FontecaveSS,
pubmed-author:GrentzingerAA,
pubmed-author:GrollierGG,
pubmed-author:LablancheJ MJM,
pubmed-author:LegrandVV,
pubmed-author:LussonJ RJR,
pubmed-author:MacayaCC,
pubmed-author:MasquetCC,
pubmed-author:McFaddenE PEP,
pubmed-author:MeneveauNN,
pubmed-author:MetzgerJ PJP,
pubmed-author:TobelemGG,
pubmed-author:VEGATT,
pubmed-author:VacheronAA,
pubmed-author:VahanianAA,
pubmed-author:d'AzemarPP,
pubmed-author:de BruyneBB
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
18
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3396-402
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9396433-Adolescent,
pubmed-meshheading:9396433-Adult,
pubmed-meshheading:9396433-Aged,
pubmed-meshheading:9396433-Angioplasty, Balloon, Coronary,
pubmed-meshheading:9396433-Anticoagulants,
pubmed-meshheading:9396433-Coronary Angiography,
pubmed-meshheading:9396433-Coronary Disease,
pubmed-meshheading:9396433-Double-Blind Method,
pubmed-meshheading:9396433-Female,
pubmed-meshheading:9396433-Hemorrhage,
pubmed-meshheading:9396433-Humans,
pubmed-meshheading:9396433-Male,
pubmed-meshheading:9396433-Middle Aged,
pubmed-meshheading:9396433-Nadroparin,
pubmed-meshheading:9396433-Prospective Studies,
pubmed-meshheading:9396433-Recurrence,
pubmed-meshheading:9396433-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale.
|
|
pubmed:affiliation |
Centre Hospitalier Regional et Universitaire Lille, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
